288 related articles for article (PubMed ID: 2678002)
21. Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene.
van der Feltz MJ; Shivji MK; Allen PB; Heisterkamp N; Groffen J; Wiedemann LM
Nucleic Acids Res; 1989 Jan; 17(1):1-10. PubMed ID: 2911461
[TBL] [Abstract][Full Text] [Related]
22. bcr rearrangement and C-abl gene expression in Ph1-positive hybrid acute leukemia with simultaneous proliferation of lymphoid and myeloid blasts.
Okabe M; Oita M; Kunieda Y; Matsuura J; Sakurada K; Matsushima S; Kakinuma M; Miyazaki T
Blut; 1989 May; 58(5):241-6. PubMed ID: 2655744
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of breakpoints on BCR gene in acute leukemia patients with Ph1 chromosome].
Tanaka K; Takechi M; Shigeta C; Oguma N; Kamada N; Takimoto Y; Kuramoto A; Kyo T; Dohi H; Nakamura Y
Rinsho Ketsueki; 1992 Jan; 33(1):1-10. PubMed ID: 1545509
[TBL] [Abstract][Full Text] [Related]
24. Consistent involvement of the 3' half part of the first BCR intron in adult Philadelphia-positive leukaemia without M-bcr rearrangement.
Nakamura Y; Hirosawa S; Aoki N
Br J Haematol; 1993 Jan; 83(1):53-7. PubMed ID: 8435337
[TBL] [Abstract][Full Text] [Related]
25. Philadelphia chromosome-positive chronic myelogenous leukemia with deleted fusion of BCR and ABL genes.
Ohyashiki K; Ohyashiki JH; Iwabuchi H; Tauchi T; Iwabuchi A; Toyama K
Jpn J Cancer Res; 1990 Jan; 81(1):35-42. PubMed ID: 2157692
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of a new Ph1-positive ALL cell line (ALL/MIK) presenting bcr gene rearrangement on bcr-2 and ALL-type bcr/abl transcript: suggestion of in vitro differentiation to monocytoid lineage.
Higa T; Okabe M; Kunieda Y; Kodama S; Itaya T; Kurosawa M; Sakurada K; Maekawa I; Shoji M; Kasai M
Leuk Lymphoma; 1994 Jan; 12(3-4):287-96. PubMed ID: 8167560
[TBL] [Abstract][Full Text] [Related]
27. Duplication of small segments within the major breakpoint cluster region in chronic myelogenous leukemia.
Litz CE; McClure JS; Copenhaver CM; Brunning RD
Blood; 1993 Mar; 81(6):1567-72. PubMed ID: 8453102
[TBL] [Abstract][Full Text] [Related]
28. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia.
Jeffs AR; Benjes SM; Smith TL; Sowerby SJ; Morris CM
Hum Mol Genet; 1998 May; 7(5):767-76. PubMed ID: 9536079
[TBL] [Abstract][Full Text] [Related]
29. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
30. Molecular methods to detect the Philadelphia chromosome.
Hooberman AL; Westbrook CA
Clin Lab Med; 1990 Dec; 10(4):839-55. PubMed ID: 2272177
[TBL] [Abstract][Full Text] [Related]
31. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.
Hermans A; Heisterkamp N; von Linden M; van Baal S; Meijer D; van der Plas D; Wiedemann LM; Groffen J; Bootsma D; Grosveld G
Cell; 1987 Oct; 51(1):33-40. PubMed ID: 2820585
[TBL] [Abstract][Full Text] [Related]
32. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the translocation breakpoint sequences in Philadelphia-positive acute lymphoblastic leukemia.
Papadopoulos PC; Greenstein AM; Gaffney RA; Westbrook CA; Wiedemann LM
Genes Chromosomes Cancer; 1990 Jan; 1(3):233-9. PubMed ID: 2083218
[TBL] [Abstract][Full Text] [Related]
34. Molecular characterization of variant translocations in chronic myelogenous leukemia.
Verma RS; Macera MJ; Benn P; Groffen J
Oncogene; 1989 Sep; 4(9):1145-8. PubMed ID: 2674857
[TBL] [Abstract][Full Text] [Related]
35. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
Grossman A; Silver RT; Arlin Z; Coleman M; Camposano E; Gascon P; Benn PA
Am J Hum Genet; 1989 Nov; 45(5):729-38. PubMed ID: 2683759
[TBL] [Abstract][Full Text] [Related]
36. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
37. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia.
Saglio G; Guerrasio A; Rosso C; Zaccaria A; Tassinari A; Serra A; Rege-Cambrin G; Mazza U; Gavosto F
Blood; 1990 Nov; 76(9):1819-24. PubMed ID: 2224129
[TBL] [Abstract][Full Text] [Related]
38. Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia.
De Klein A
Mutat Res; 1987 Sep; 186(2):161-72. PubMed ID: 3306360
[TBL] [Abstract][Full Text] [Related]
39. The BCR/ABL hybrid gene.
Groffen J; Heisterkamp N
Baillieres Clin Haematol; 1987 Dec; 1(4):983-99. PubMed ID: 3332859
[TBL] [Abstract][Full Text] [Related]
40. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
Campbell ML; Li W; Arlinghaus RB
Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
